Literature DB >> 30251380

Association of Hospitalization, Critical Illness, and Infection with Brain Structure in Older Adults.

Keenan A Walker1, Rebecca F Gottesman1,2, Aozhou Wu2, David S Knopman3, Thomas H Mosley4, Alvaro Alonso5, Anna Kucharska-Newton6, Charles H Brown7.   

Abstract

OBJECTIVES: To examine the association between hospitalization, critical illness, and infection occurring during middle- and late-life and structural brain abnormalities in older adults.
DESIGN: Prospective cohort study.
SETTING: Atherosclerosis Risk in Communities (ARIC) Study. PARTICIPANTS: A community sample of adults who were 44 to 66 years of age at study baseline. MEASUREMENTS: Active surveillance of local hospitals and annual participant contact were used to gather hospitalization information (including International Classification of Diseases, Ninth Revision, codes) on all participants over a 24-year surveillance period. Subsequently, a subset of participants underwent 3-Tesla brain magnetic resonance imaging (MRI) to quantify total and regional brain volumes, white matter hyperintensity (WMH) volume, and white matter microstructural integrity (fractional anisotropy (FA) and mean diffusivity (MD) as measured using diffusion tensor imaging (DTI)).
RESULTS: Of the 1,689 participants included (mean age at MRI 76±5), 72% were hospitalized, 14% had a major infection, and 4% had a critical illness during the surveillance period. Using covariate-adjusted regression, hospitalization was associated with 0.12-standard deviation (SD) greater WMH volume (95% confidence interval (CI)=0.00-0.24) and poorer white matter microstructural integrity (0.17-SD lower FA, 95% CI=-0.27 to -0.06; 0.16-SD greater MD, 95% CI=0.07-0.25) than no hospitalization. There was a dose-dependent relationship between number of hospitalizations, smaller brain volumes, and lower white matter integrity (p-trends ≤.048). In hospitalized participants, critical illness was associated with smaller Alzheimer's disease (AD) signature region (-1.64 cm3 , 95% CI=-3.16 to -0.12); major infection was associated with smaller AD signature region (-1.28 cm3 , 95% CI=-2.21 to -0.35) and larger ventricular volume (3.79 cm3 , 95% CI= 0.81-6.77).
CONCLUSIONS: Whereas all-cause hospitalization was primarily associated with lower white matter integrity, critical illness and major infection were associated with smaller brain volume, particularly within regions implicated in AD.
© 2018, Copyright the Author Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  Alzheimer's disease; dementia; magnetic resonance imaging; risk factor

Mesh:

Year:  2018        PMID: 30251380      PMCID: PMC6181772          DOI: 10.1111/jgs.15470

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  34 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Cognitive decline after hospitalization in a community population of older persons.

Authors:  R S Wilson; L E Hebert; P A Scherr; X Dong; S E Leurgens; D A Evans
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

3.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

4.  Association between sepsis and dementia.

Authors:  Li-Ting Kao; Jau-Jiuan Sheu; Herng-Ching Lin; Ming-Chieh Tsai; Shiu-Dong Chung
Journal:  J Clin Neurosci       Date:  2015-07-10       Impact factor: 1.961

Review 5.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

6.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

7.  Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.

Authors:  Jin G Sheng; Susan H Bora; G Xu; David R Borchelt; Donald L Price; Vassilis E Koliatsos
Journal:  Neurobiol Dis       Date:  2003-10       Impact factor: 5.996

8.  Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

Authors:  R E Guevara; J C Butler; B J Marston; J F Plouffe; T M File; R F Breiman
Journal:  Am J Epidemiol       Date:  1999-02-01       Impact factor: 4.897

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Bidirectional relationship between cognitive function and pneumonia.

Authors:  Faraaz Ali Shah; Francis Pike; Karina Alvarez; Derek Angus; Anne B Newman; Oscar Lopez; Judith Tate; Vishesh Kapur; Anthony Wilsdon; Jerry A Krishnan; Nadia Hansel; David Au; Mark Avdalovic; Vincent S Fan; R Graham Barr; Sachin Yende
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

View more
  2 in total

1.  Inflammation and neurodegeneration: chronicity matters.

Authors:  Keenan A Walker
Journal:  Aging (Albany NY)       Date:  2018-12-16       Impact factor: 5.682

2.  Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline.

Authors:  Bryan D James; Robert S Wilson; Ana W Capuano; Patricia A Boyle; Raj C Shah; Melissa Lamar; E Wesley Ely; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2019-10-23       Impact factor: 10.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.